Quantifying viral infection begins at the molecular level. In laboratories around the world, scientists use quantitative PCR (qPCR) to detect tiny amounts of viral genetic material and estimate viral load. This powerful technology allows researchers and clinicians to measure infection in real time and guide both diagnostics and outbreak response.
Brazil’s Zika and chikungunya outbreaks are shaped by more than climate. Spatial analysis shows urban density, poor sanitation, and inequality significantly increase cluster risk. Even after adjusting for geography, socioeconomic conditions remain core drivers, linking arbovirus transmission directly to infrastructure and development gaps.
Zika and chikungunya outbreaks in Brazil move together, not separately. Space-time analysis reveals overlapping clusters driven by shared Aedes aegypti dynamics, summer heat, and regional climate conditions. When ecological risk rises, multiple arboviruses surge simultaneously — reinforcing the need for surveillance systems that anticipate co-circulating threats, not isolated outbreaks.
In the lab, scientists don’t ask cells questions — they measure gene expression. By tracking RNA, the messages genes send when they’re active, researchers can see whether cells are fighting infection, responding to treatment, or changing behavior. Techniques like qPCR, RNA sequencing, and single-cell analysis help decode these molecular signals.
Scientists don’t just count cases to detect outbreaks — they use spatial tools to find hidden patterns in disease spread. This article explains how scan statistics work and why univariate and multivariate approaches help reveal outbreak clusters and shared transmission environments across regions.
PCR and antigen tests both detect viruses, but they work in very different ways. PCR amplifies viral genetic material for highly sensitive detection, while antigen tests identify viral proteins for faster results. Understanding when to use each test helps guide diagnosis, screening, and public-health decisions.
Dengue in Puerto Rico is shifting fast. Adults now make up most cases, hospitalizations exceed 50%, and DENV-3 has replaced DENV-1 as the dominant strain. These changes signal a new epidemiologic phase — and may warn of similar outbreaks emerging across Latin America.
Natural insect repellents are increasingly popular across Latin America, but most offer little real protection. A 2023 study tested plant-based ingredients against mosquitoes and ticks and found that only a few—cinnamon oil, clove oil, and geraniol—provided meaningful, multi-vector repellency. This blog breaks down which natural repellents actually work and what that means for real-world disease prevention.
Natural repellents are widely used across Latin America, but most fail to prevent mosquito bites. New evidence shows only a small number of plant-based ingredients provide real, short-term protection—highlighting the risks of relying on ineffective products.
Metronidazole remains a first-line therapy for Helicobacter pylori in Latin America, despite widespread resistance. Because the drug requires intracellular activation to damage bacterial DNA, even small disruptions in bacterial metabolism can render it ineffective, driving treatment failure, persistent infection, and preventable disease.
An 18-year pediatric cohort study from Nicaragua shows that dengue, chikungunya, and Zika symptoms change with age and over the first 10 days of illness. Fever patterns, rashes, and blood markers evolve differently across childhood, revealing diagnostic clues that static symptom checklists often miss. Tracking symptom trajectories over time leads to more accurate differentiation of these infections.
Metronidazole is rapidly failing as a first-line Helicobacter pylori treatment in Latin America. High resistance rates in Colombia, Peru, and Brazil exceed safe empiric thresholds, driving treatment failure, persistent infection, and increased gastric cancer risk.
